Shopping Cart
Remove All
Your shopping cart is currently empty
Motavizumab
😃Good
Catalog No. T76752Cas No. 677010-34-3
Alias MEDI-524, MEDI524
Motavizumab (MEDI-524) is a monoclonal antibody neutralizing respiratory syncytial virus (RSV), altering local and systemic cytokine responses in mouse models, used in the study of RSV infection.
Motavizumab
Motavizumab
😃Good
Catalog No. T76752Alias MEDI-524, MEDI524Cas No. 677010-34-3
Motavizumab (MEDI-524) is a monoclonal antibody neutralizing respiratory syncytial virus (RSV), altering local and systemic cytokine responses in mouse models, used in the study of RSV infection.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $579 | In Stock | In Stock | |
| 10 mg | $892 | - | In Stock | |
| 25 mg | $1,350 | - | In Stock | |
| 50 mg | $1,820 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.17% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Motavizumab (MEDI-524) is a monoclonal antibody neutralizing respiratory syncytial virus (RSV), altering local and systemic cytokine responses in mouse models, used in the study of RSV infection. |
| Targets&IC50 | mIgA1:0.1986 nM (EC50), mIgA2:0.2976 nM(EC50), IgG1:0.07823 nM (EC50) |
| In vivo | In a mouse model, prophylactic administration of Motavizumab (1.25 mg/ mouse) significantly reduced respiratory syncytial virus (RSV) replication, local and systemic cytokine responses, especially TNF-α, IL-1α, IL-12p70, KC, IL-10, and INF-γ. And completely prevented the development of clinically acute RSV disease. [1] |
| Synonyms | MEDI-524, MEDI524 |
| Reactivity | Virus |
| Verified Activity | Immobilized Human RSV post-F Protein (His) at 2 μg/mL can bind Motavizumab. The EC50 is 0.004796 μg/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | RSV-F |
| Molecular Weight | 145.32 kDa |
| Cas No. | 677010-34-3 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Motavizumab | purchase Motavizumab | Motavizumab cost | order Motavizumab | Motavizumab in vivo | Motavizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.